JPH0586043A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPH0586043A
JPH0586043A JP4085120A JP8512092A JPH0586043A JP H0586043 A JPH0586043 A JP H0586043A JP 4085120 A JP4085120 A JP 4085120A JP 8512092 A JP8512092 A JP 8512092A JP H0586043 A JPH0586043 A JP H0586043A
Authority
JP
Japan
Prior art keywords
disorder
active ingredient
preventing
cerebral
treating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4085120A
Other languages
English (en)
Japanese (ja)
Inventor
Sakae Murata
栄 村田
Tsutomu Kobayashi
力 小林
Rikako Yamauchi
理夏子 山内
Isao Yamaguchi
山口　　勲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP4085120A priority Critical patent/JPH0586043A/ja
Publication of JPH0586043A publication Critical patent/JPH0586043A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
JP4085120A 1991-02-26 1992-02-20 医薬組成物 Pending JPH0586043A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4085120A JPH0586043A (ja) 1991-02-26 1992-02-20 医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3-117061 1991-02-26
JP11706191 1991-02-26
JP4085120A JPH0586043A (ja) 1991-02-26 1992-02-20 医薬組成物

Publications (1)

Publication Number Publication Date
JPH0586043A true JPH0586043A (ja) 1993-04-06

Family

ID=14702461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4085120A Pending JPH0586043A (ja) 1991-02-26 1992-02-20 医薬組成物

Country Status (10)

Country Link
EP (1) EP0501442B1 (de)
JP (1) JPH0586043A (de)
KR (1) KR920016099A (de)
AT (1) ATE131057T1 (de)
CA (1) CA2061353A1 (de)
DE (1) DE69206447T2 (de)
DK (1) DK0501442T3 (de)
ES (1) ES2083605T3 (de)
FR (1) FR2673106B1 (de)
GR (1) GR3018320T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103816462A (zh) * 2012-11-16 2014-05-28 丁徽 一种治疗中风偏瘫的中药

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85257A (en) * 1987-02-10 1993-02-21 Tanabe Seiyaku Co Pharmaceutical compositions containing 2-(4-methoxyphenyl) 3-acetoxy-5-- (2-(dimethylamino) ethyl) -8-chloro-2,3- dihydro-1,5-benzothiazepin -4 (5h)-one having renal function-improving effect and diuretic effect
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EUR.J.PHARMACOLOGY,183-3=1990 *

Also Published As

Publication number Publication date
FR2673106B1 (fr) 1995-06-16
DE69206447T2 (de) 1996-06-05
DK0501442T3 (da) 1996-01-08
FR2673106A1 (fr) 1992-08-28
ATE131057T1 (de) 1995-12-15
GR3018320T3 (en) 1996-03-31
EP0501442A1 (de) 1992-09-02
CA2061353A1 (en) 1992-08-27
DE69206447D1 (de) 1996-01-18
EP0501442B1 (de) 1995-12-06
KR920016099A (ko) 1992-09-24
ES2083605T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
RU2005135958A (ru) Способ лечения с использованием лекарственных форм, содержащих фармацевтические композиции 5, 8, 14-триазатетрацикло[10.3.1.02,11.04,9]-гексадека-2( 11 ), 3,5,7,9-пентаена
EP0220696A2 (de) Verwendung von Buspiron zur Herstellung von pharmazeutischen Zusammensetzungen zur Linderung von krankhaften Angst
US9815827B2 (en) Agent for treatment of schizophrenia
US12291528B2 (en) Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
SK281982B6 (sk) Použitie zlúčenín gabapentínu na výrobu liečiva
JP2002518449A (ja) 高血中コレステロールを治療する組成物および方法
US20020077355A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
US4906649A (en) Use of a compound for the treatment of sleep disorders and depression
US5382577A (en) Pharmaceutical composition for inhibiting platelet aggregation
BG62120B1 (bg) Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1
EP1420782B1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
JPH0586043A (ja) 医薬組成物
HUT50440A (en) Process for producing pharmaceutical compositions for treating schizophrenia
WO2024176131A1 (en) Tead- and kras g12d-inhibitor combinations for treating cancer
CN1325308A (zh) 使用神经营养因子刺激素治疗眼科神经退变性疾病
CN1250218C (zh) 血管紧张素拮ⅱ抗剂的新用途
AU742873B2 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
EP3923937B1 (de) Kombinationen von dexamethason und indomethacin mit thiazolidindione zur verwendung in der vorbeugung oder behandlung von abnormalem knochenwachstum
IL145799A (en) Use of nefiracetam in the preparation of a drug to improve the daily life activities of patients after a stroke
JP5376786B2 (ja) 神経細胞賦活組成物
US4711891A (en) Use of terguride as a geriatric agent
US4795759A (en) Use of dibenz(CD,F)indoles
HU228302B1 (en) Use of levosimendan for the treatment or prevention of coronary graft vasospasm
Alkondon et al. Tissue cholinesterase inhibition by propranolol and related drugs
US4609656A (en) Medical agent for improving and treating mental symptoms induced by cerebral disturbances